Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK-Positive Lung Cancer.

MLA

Shrestha, N., et al. “Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK-Positive Lung Cancer.” The Journal of Pharmacology and Experimental Therapeutics, vol. 374, no. 1, July 2020, pp. 134–40. EBSCOhost, https://doi.org/10.1124/jpet.120.266049.

APA

Shrestha, N., Bland, A. R., Bower, R. L., Rosengren, R. J., & Ashton, J. C. (2020). Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK-Positive Lung Cancer. The Journal of Pharmacology and Experimental Therapeutics, 374(1), 134–140. https://doi.org/10.1124/jpet.120.266049

Chicago

Shrestha, N, A R Bland, R L Bower, R J Rosengren, and J C Ashton. 2020. “Inhibition of Mitogen-Activated Protein Kinase Kinase Alone and in Combination with Anaplastic Lymphoma Kinase (ALK) Inhibition Suppresses Tumor Growth in a Mouse Model of ALK-Positive Lung Cancer.” The Journal of Pharmacology and Experimental Therapeutics 374 (1): 134–40. doi:10.1124/jpet.120.266049.